Stochastic analysis of a COVID-19 model with effects of vaccination and different transition rates: Real data
Changjin Xu1, Zixin Liu2, Yicheng Pang2
1Guizhou Key Laboratory of Economics System Simulation, Guizhou University of Finance and Economics, Guiyang 550025, PR China.
Abstract:
This paper presents a stochastic model for COVID-19 that takes into account factors such as incubation times, vaccine effectiveness, and quarantine periods in the spread of the virus in symptomatically contagious populations. The paper outlines the conditions necessary for the existence and uniqueness of a global solution for the stochastic model. Additionally, the paper employs nonlinear analysis to demonstrate some results on the ergodic aspect of the stochastic model. The model is also simulated and compared to deterministic dynamics. To validate and demonstrate the usefulness of the proposed system, the paper compares the results of the infected class with actual cases from Iraq, Bangladesh, and Croatia. Furthermore, the paper visualizes the impact of vaccination rates and transition rates on the dynamics of infected people in the infected class.
Related Concept Videos
Steps in Outbreak Investigation
Statistical Methods for Analyzing Epidemiological Data
Causality in Epidemiology
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Parametric Survival Analysis: Weibull and Exponential Methods
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...


